Dangerous Synthetic Drug Control Act of 2016

Summary

Dangerous Synthetic Drug Control Act of 2016 This bill amends the Controlled Substances Act to add certain synthetic opioids, hallucinogens, and cannabinoids to schedule I. (A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 6 September 2016

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

2. 6 September 2016

   Introduced

   Introduced in House

   Source: IntroReferral

3. 6 September 2016

   Introduced

   Introduced in House

   Source: IntroReferral

4. 6 September 2016

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

5. 15 September 2016

   Referred

   Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 6 September 2016 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 6 September 2016

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 6 September 2016

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 6 September 2016

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Katko, John [R-NY-24] · R · Sponsor
• Rep. Cicilline, David N. [D-RI-1] · D · Sponsor
• Rep. Dent, Charles W. [R-PA-15] · R · Sponsor
• · hsju00 · Standing
• · hsif00 · Standing

Related records

• related to → Dangerous Synthetic Drug Control Act of 2016
• related to → Dangerous Synthetic Drug Control Act of 2016